期刊文献+

破骨细胞在强直性脊柱炎滑膜组织浸润及与软骨破坏的相关性 被引量:2

Osteoclast infiltration in synovium of ankylosing spondylitis and its relationship to cartilage damage
下载PDF
导出
摘要 目的检测强直性脊柱炎(ankylosing spondylitis,AS)患者滑膜组织中破骨细胞浸润,探讨破骨细胞与软骨破坏相关性。方法采用酶组织化学技术检测滑膜组织内破骨细胞,Mankin评分检测软骨破坏情况,Leika Qwin高清晰图像分析系统测定阳性染色面积,相关分析分析破骨细胞表达与软骨破坏的相关性。结果破骨细胞在滑膜组织内阳性浸润,并主要分布在滑膜衬里层及滑膜与软骨交界处,阳性染色面积与对照组有显著差异,破骨细胞的浸润与软骨的破坏程度显著相关(r=0.654,P=0.001)。结论AS滑膜组织中有破骨细胞浸润,并与软骨的破坏程度具有相关性,在AS骨与软骨的破坏过程中发挥着重要的作用。 objective To detect the infiltration of osteoclast in synovium of ankylosing spondylitis(AS) and to explore the relationship of osteoclast to cartilage damage.Methods Using the enzymohistochemistry to detect the osteoclast phenotype in synovium of the AS;using Leika Qwin analytical system to determine positive staining areas.Degree of the cartilaginous damage in AS was observed with Mankin score;dependability between osteoclast and cartilage damage was evaluated with Spearman correlation analysis.Results Ta...
出处 《免疫学杂志》 CAS CSCD 北大核心 2009年第1期77-79,共3页 Immunological Journal
关键词 强直性脊柱炎 破骨细胞 软骨破坏 ankylosing spondylitis cartilage damage osteoclast
  • 相关文献

参考文献1

二级参考文献22

  • 1Toussirot E, Ricard-Blum S, Dumoulin G, et al. Relationship between urinary pyridinium cross-links, disease activity and disease suhsets of ankylosing spondylitis. Rheumatol (Oxford), 1999, 38:21-27.
  • 2Toussirot E, Michel F, Auge B, et al. Bone mass, body composition and bone ultrasound measurements in ankylosing spondylitis.Arthritis Rheum, 1999, 42(Suppl): 356.
  • 3Bernecker PM, Aringer M, et al. Ankylosing spondylitis,arthritis, and reactive arthritis show increased bone rebut differ with regard to bone formation. J Rheumatol,2002,29:1430-1436.
  • 4Maksymowych WP. Ankylosing spondylitis: at the interface of bone and cartilage. J Rheumatol, 2000, 27: 2295-3301.
  • 5Braun J, Bollow M, Sieper J. Radiologic diagnosis and pathology of the spondyloarthropathies. Rheum Dis Clin North Am, 1998,24:697-736.
  • 6Bekker PJ, Holloway D, Nakanishi A, et al. Osteoprotegerin has potent and sustained anti-resorptive activity in postmenopausal women. J Bone Miner Res, 1999, 14(Suppl 1):1190.
  • 7Hotbauer LC, Khosla S, Dunstan CR, et al. The role of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res, 2000, 15: 2-12.
  • 8Mori H, Kitazawa R, Maeda S, et al. RANK ligand, RANK, and OPG expression in type Ⅱ collagen-induced arthritis mouse.Histochem Cell Biol, 2002, 117: 283-292.
  • 9Gravallese EM, Manning C, Tsay A, et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.Arthritis Rheum, 2000, 43: 250-258.
  • 10Yukio S, Thomas P, Peter K, et al. Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthritis Rheum, 2000,43: 2523-2530.

共引文献16

同被引文献28

  • 1Tam IS, Gu J, Yu D. Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol, 2010, 6: 399-405.
  • 2Maksymowych WP, Chiowchanwisawakit P, Clare T, et al. In- flanunatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum, 2009, 60: 93-102.
  • 3Redlich K, Hayer S, Ricci R, et al. Osteoclast are essential for TNF-a-mediated joint destruction. J Clin Invest, 2004, 110: 1419-1427.
  • 4Smith JA, Barnes MD, Hong D, et al. Gene expression analysis of macrophages derived from ankylosing spondylitis patients re- veals interferen-gamma dysregulation. Arthritis Rheum, 2008, 58: 1640-1649.
  • 5Yen ML, Hsu PN, Liao I-IJ, et al. TRAF-6 dependent signaling pathway is essential for TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation. PLoS One, 2012, 7: e38048.
  • 6Mochizuki A, Takami M, Miyamoto Y, et al. Cell adhesion sig- naling regulates RANK expression in osteoclast precursors. PLoS One, 2012, 7: e48795.
  • 7Zehnder AF, Kristiansen AG, Adams JC, et al. Osteopretegrin knockout mice demonstrate abnormal remodeling of the otic cap- sule and progressive heating loss. J Laryngoscope, 2006, 116: 201-206.
  • 8Wijenayaka AR, Kogawa M, Lim HP, et al. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. PLoS One, 2011, 6: e25900.
  • 9Kobayashi Y, Udagawa N, Takahashi N. Action of RANKL and OPG for osteoclastogenesis. Crit Rev Eukaryot C, ene Expr, 2009, 19: 61-72.
  • 10Chela CH, Chen HA, Li HT, et al. Soluble receptor activator of nuelear factor-KB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mo- bility and refleets systemic inflammation. Clin Rheumatol, 2010, 29: 1155-1161.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部